Evidence map›Paper›PMID 39596177›Full record

ReviewInternational journal of molecular sciences2024

Pathological Mechanisms of Particulate Matter-Mediated Ocular Disorders: A Review.

Jung-Hwa Han, Chaima Amri, Hyesook Lee, Jin Hur

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jung-Hwa HanDepartment of Convergence Medicine, Pusan National University School of Medicine, Busan 50612, Republic of Korea.ORCID 0000-0002-8030-7461
Chaima AmriDepartment of Convergence Medicine, Pusan National University School of Medicine, Busan 50612, Republic of Korea.
Hyesook LeeDepartment of Convergence Medicine, Pusan National University School of Medicine, Busan 50612, Republic of Korea.ORCID 0000-0003-3546-9370
Jin HurDepartment of Convergence Medicine, Pusan National University School of Medicine, Busan 50612, Republic of Korea.ORCID 0000-0003-0692-0150

Funding

2-Year Research Grant of Pusan National University 2023
6 · The paper itself

Abstract

Air pollution presents a severe risk to public health, with particulate matter (PM) identified as a significant hazardous element. However, despite the eye organ being constantly exposed to air pollution, only recently has the impact of PM on ocular health caught the attention of researchers and healthcare professionals. By compiling pertinent data, this paper aims to enhance our understanding of the underlying pathological mechanisms of PM-mediated ocular disorders and facilitate the development of effective treatment strategies. Recent data support the association between exposure to PM and the development of ocular pathologies such as dry eye syndrome, retinal atherosclerosis, and glaucoma. Based on the results of multiple studies, PM exposure can lead to oxidative stress, inflammation, autophagy, cell death, and, ultimately, the development of ophthalmic diseases. This review aims to consolidate the latest findings on PM-mediated ocular diseases by summarizing the outcomes from epidemiological, in vitro, and in vivo studies on ocular surface and retinal disorders as well as other relevant ophthalmic disorders.

Indexed as

Eye DiseasesParticulate MatterAir PollutantsAir PollutionAnimalsAutophagyHumansOxidative StressAir PollutantsParticulate Matterair pollutionfine dustocular surfaceoxidative stressparticulate matterretinal disorders

Identifiers

PMID39596177
PMCPMC11594968

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.